Search results
Entrada Therapeutics (NASDAQ:TRDA) versus BioLineRx (NASDAQ:BLRX) Head to Head Comparison
ETF DAILY NEWS· 3 days agoBioLineRx (NASDAQ:BLRX – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...
After-hours movers: Broadcom, Dave & Buster's, Oxford Industries, and more
Investing.com· 6 days agoBroadcom (NASDAQ: AVGO ) rose 10% after beating EPS and revenue estimates for the second quarter and...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 6 days agoThe stock is, therefore, an attractive turnaround investment, as its pipeline is being regenerated. Attractive pipeline and potential growth catalysts...
Pfizer’s gene therapy for a muscle-wasting disorder misses main goal of late-stage study
WHTC 1450 Holland· 5 days ago(Reuters) - Pfizer said on Wednesday its experimental gene therapy for a type of muscle-wasting...
Dyne Therapeutics, Inc. (NASDAQ:DYN) Insider Oxana Beskrovnaya Sells 2,136 Shares
ETF DAILY NEWS· 6 days agoDyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Oxana Beskrovnaya sold 2,136 shares of Dyne Therapeutics stock in a transaction on Tuesday, June 11th. The stock was sold at an ...
Susanna Gatti High Sells 40,000 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock
ETF DAILY NEWS· 3 days agoDyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) COO Susanna Gatti High sold 40,000 shares of Dyne Therapeutics stock in a transaction that occurred on Wednesday, June 12th. Following ...
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
The West Side Index & Gustine Press-Standard· 4 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Rockville drugmaker's longtime CEO stepping down - Washington Business Journal
The Business Journals· 6 days agoFor the first time in its 15-year existence, Rockville’s RegenxBio Inc. (NASDAQ: RGNX) is about to...
Perry para-athlete’s road to a second state shot put title aided by special chair constructed by...
The Argus-Press· 19 hours agoThis spring, an innocuous Instagram video served as a catalyst for a project that had a major impact...
Clare Kahn, director at Solid Biosciences, buys $8.4k in stock By Investing.com
Investing.com· 7 days agoClare Kahn, a director of Solid Biosciences Inc. (NASDAQ:SLDB), a company specializing in biological...